The Hospital for Endocrine Surgery, a well-known facility specializing in treating the thyroid, parathyroid, and adrenal glands, has announced that it had treated its 10,000th surgical patient just two years after opening its doors in January 2022. The hospital has become a top destination for endocrine surgery, performing more than five times as many procedures as any other hospital in the United States.
The Clayman Thyroid Center, the world’s highest-volume thyroid surgery practice, treated the 10,000th patient on February 27, 2024. Ari Fischer, a 51-year-old patient from Ecuador diagnosed with papillary thyroid cancer, traveled to the Hospital for Endocrine Surgery seeking expert surgical care. Like 60% of the hospital’s patients, Mr. Fischer lives outside of Florida.
Mr. Fischer was referred to the Clayman Thyroid Center by several doctors he knows who highly recommended the hospital. The Center’s high-volume expertise and the seamless and stress-free process for traveling patients convinced him to make the journey to Tampa. The Center offers a unique one-day evaluation and surgery process, allowing patients to undergo a comprehensive thyroid assessment and surgery within a single day.
After their surgery, patients can rest comfortably overnight at one of the four partner hotels before returning home the next day. The surgeons work closely with the patient’s local healthcare providers to coordinate ongoing care, eliminating the need for additional travel back to Tampa. Additionally, the Center provides a private shuttle service to transport patients to and from the airport and the hospital, eliminating the need for them to rent a car or worry about transportation logistics.
“We are deeply honored to have reached this significant milestone of treating our 10,000th patient,” remarked Dr. Gary Clayman, founder of the Clayman Thyroid Center. “Each patient represents a unique journey, and it is our privilege to guide them towards healing and recovery. Mr. Fischer’s decision to travel across continents to seek treatment at our facility speaks volumes about the trust and confidence patients place in our expertise.”
The Clayman Thyroid Center provides exceptional care for patients with thyroid conditions, offering a comprehensive range of services from diagnosis to treatment and post-operative support.
“Our mission goes beyond surgical success; it is about empowering patients to reclaim their health and well-being,” added Dr. Rashmi Roy, Director of Thyroid Surgical Services and Senior Surgeon at the Clayman Thyroid Center. “We strive to create a supportive environment where patients feel heard, valued, and empowered throughout their treatment journey. Mr. Fischer’s journey is a testament to the transformative impact of compassionate, patient-centered care.”
As the Clayman Thyroid Center celebrates this momentous occasion, it reaffirms its commitment to advancing the field of endocrine surgery, driving innovation, and improving outcomes for patients worldwide.
“We never stop striving to innovate and offer our patients the latest in technological and treatment advancements,” said Dr. Hyunsuk Suh, Founder of the Suh Scarless Thyroid Center. “We perform more scarless robotic thyroid operations than anyone else in the country, and we are pleased to begin offering radiofrequency ablation (RFA) for benign thyroid nodules within the next month.”
The Clayman Thyroid Center, Norman Parathyroid Center, and Carling Adrenal Center operate together at the Hospital for Endocrine Surgery to form the largest endocrine surgery practice in the world.